Late-Onset Neutropenia After Rituximab-Containing Therapy for Non-Hodgkin Lymphoma

Chronic neutropenia mediated by Fas ligand

Jin Hong Liu, Sheng Wei, Thierry Lamy et al. · Blood · 2000 · 163 citations

Late‐onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections

Daniel Tesfa, Sofia Ajeganova, Hans Hägglund et al. · Arthritis & Rheumatism · 2011 · 151 citations

Delayed‐onset neutropenia associated with rituximab therapy

Kritika Chaiwatanatorn, Newton Lee, Andrew Grigg et al. · British Journal of Haematology · 2003 · 146 citations

Hematological Malignancy, Lymphoid Neoplasia, Bone Marrow Failure +13

B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis

Kieron Dunleavy, Frances T. Hakim, Hyun Kyung Kim et al. · Blood · 2005 · 134 citations · Full text

Delayed-onset peripheral blood cytopenia after rituximab: Frequency and risk factor assessment in a consecutive series of 77 treatments

Chiara Cattaneo, Pierangelo Spedini, Salvatore Casari et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 114 citations